Hematopoietic and Lymphoid Cell Neoplasm

Hematopoietic and Lymphoid Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

18,680 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 451–500 of 5,089 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06308822	Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1)	active not recruiting	Phase 2	35	National Cancer Institute (NCI)NIH	1	Sep 15, 2026	clinicaltrials
NCT06423911	Study of Olverembatinib (HQP1351) in Patients With CML-CP(POLARIS-2)	recruiting	Phase 3	333	Ascentage Pharma Group Inc.INDUSTRY	16	Sep 15, 2026